Summary

Summary This position will be located at either the Cambridge, MA site or the East Hanover, NJ site and will not have the ability to be located remotely.

The Executive Director, Product Strategy Lead (PSL) will lead the creation, implementation, orchestration and measurement of the integrated product strategies for an indication of a launch product within Neuroscience in the US, under the leadership of a General Manager in Neuroscience. This individual will contribute to the key decision making for maximizing the impact of the product under their remit while actively and appropriately managing resource allocation across multiple teams, and multiple functions. This will be done in consultation with various teams and functions, including: Marketing, Sales, Novartis Patient Support, Market Access, Insights and Decision Science and Medical about their respective strategies, plans and proposed resourcing. This leader will impact the Novartis legacy in his/her responsibility for accelerating impact in the product/while leading through a business-critical transformation.

This role will contribute to the management of the full P&L for the assigned product, under the final leadership of the General Manager for the Product or Portfolio and will partner closely with functional heads for decision-making of resource allocation to deliver the most accelerated impact for the product.

This leader will be a key member of the General Manager team in the Integrated Product Strategy Organization and is expected to demonstrate accountability for the assigned product or indication and responsibility for broader enterprise leadership in their decisions and engagement across the US Pharma organization.

This leader has a passion for transformational enterprise leadership, decisive strategy in service of delivering higher impact for patients, customers, healthcare systems with higher quality, speed and agility. Additionally, this leader will be responsible for ensuring that customer engagement and relationship building are factored into the product/ indications’ strategic approach and performance metrics to optimize the approach and identify potential areas of risk.